Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aida Pharmaceuticals Inc (AIDA)

Aida Pharmaceuticals Inc (AIDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aida Pharmaceuticals Inc

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Aida Pharmaceuticals Inc. was incorporated in the State of Nevada on December 18, 2002. The Company attempted to operate as a consulting firm and was not successful. The major products produced and marketed by Aida are Etimicin Sulfate Injection Powder, Etimicin Sulfate Injection liquid and Etimicin Sulfate for transfusion. Major new products under developments by Aida include: 5-Deoxy-Fluorordine. Aida has developed a new liquid for injection type of drug generated from 5-fluroruacil that has displayed better anticancer results and fewer side effects. This new product has been under clinical testing since 1998. Test results showed that it has only nominal side effects, a spectrum and is highly effective. Apoptotic Factor. Hangzhou Aida has completed the clinical study of apoptotic factor's molecular structure and pharmacological characteristics, including long-term effects and stability and has applied for patent in China. Adefovir Dipivoxil Tablets. It is a new drug used for hepatitis treatment. Fangyuan is now developing the drug. Methylcanthatidinimide For Injection. It is another new drug being developed by Fangyuan used for cancer treatment. It would be a Category B new drug. SYO2. Hangzhou Aida has created one medicine extracted from herbal essence, called SYO2 that has exhibited bioactivity for brain anti-thrombosis. The drug, developed solely by an aligned research center of Hangzhou Aida, has shown to be safe, effective and without side effects. Aida's main production facilities are located in three places. One is in Hangzhou in the Zhejiang Province, the second is in Changzhou in the Jiangsu Province and the third is in Haikou in the Hainan Province. The raw materials base and supplies for manufacturing at the plant are acquired from domestic suppliers. The main purchases include: packaging materials, chemicals and intermediates, some of which are controlled under long-term contracts. Price, quality, and promotion are the three most competitive factors in the pharmaceutical sector in China. Aida provides a special annual budget for advertising of new and major products that meet the following requirements: a clear and reproduced treatment result; a large, stable and loyal customer base; good market potential; and a long market life. Aida presently has approximately 500 employees total, with over 200 at its headquarters in Hangzhou.

Key Statistics

Overview:

Short Interest, K 0
Short Float 0.00%
Days to Cover 999.99
Short Volume Ratio 0.99

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K

Growth:

1-Year Return 50.00%
3-Year Return 0.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Dividend Payout Ratio 0.00%

AIDA Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow 1.14
Price/Book 0.77
Book Value/Share N/A
Interest Coverage N/A
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar